Search Results for: Avandia

Featured Stories

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits

A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

FDA Questions Device Makers about Duodenoscope Cleaning Procedures

Following Deadly Outbreaks, FDA Questions Device Makers about Duodenoscope Cleaning Procedures

In light of a recent outbreak linked to contaminated duodenoscopes, the U.S. Food and Drug Administration (FDA) is questioning manufacturers about their methods for cleaning the devices, the New York Times reports. The specialized scopes, which have been linked to several outbreaks in recent years, most recently infected seven patients ...

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

Transvaginal Mesh Lawsuit Trial

$5.5 Million Awarded to Plaintiffs in First Transvaginal Mesh Lawsuit Trial

An award of $5.5 million has been made in the first trial over a transvaginal mesh lawsuit. The jury found against medical device maker, C.R. Bard, and its Avaulta Plus transvaginal mesh. The jury agreed that Bard’s Avaulta Plus transvaginal mesh caused numerous and painful injuries in a California woman. ...

Read More

Soda Consumption Causes Early Puberty & Girls’ Cancer Risk

Soda Consumption Causes Early Puberty and Increases Girls’ Cancer Risk

Drinking just one-and-a-half cans of sugar-sweetened soda a day can bring on early puberty in girls and increase their breast cancer risk.

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

Avandia Test Lawsuit Settled

An < "">Avandia lawsuit that was expected to be a test case for the thousands of similar claims pending throughout the U.S. was settled on the eve of trial. GlaxoSmithKline, the maker of Avandia, had already settled around 10,000 Avandia … Continue reading

Posted in Legal News | Tagged , , , , , |

First Avandia Trial Underway in Philadelphia

The litigation surrounding < "">Avandia is finally underway. The first federal trial involving an Avandia heart attack lawsuit began yesterday. According to a Daily Finance report, GlaxoSmithKline, the maker of Avandia, has already settled around 10,000 such claims, but it … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Poses Serious Heart Risks

Type 2 diabetes drug, < "">Avandia, has long been connected to significant risks of heart attack, strokes, and heart failure. As a matter-of-fact, this September 2010, the U.S. Food & Drug Administration (FDA) placed severe restrictions on Avandia, citing these … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Subject to Restrictions in Canada

Health Canada just announced important new restrictions on the use of the following rosiglitazone products due to information on cardiovascular related events: < "">Avandia, Avandamet and Avandaryl. GlaxoSmithKline Inc., in consultation with Health Canada, released important new restrictions on the … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Black Box Warning Wasn’t Heeded by All Doctors, Study Finds

Not all doctors are heeding warnings for < "">Avandia. According to a study published in The New England Journal of Medicine that used Avandia as an example, doctors’ prescribing patterns vary across the country in response to warnings about medications … Continue reading

Posted in Pharmaceuticals |

Avandia Faces Justice Department Probe

< "">Avandia, GlaxoSmithKline’s controversial diabetes drug, is coming under more scrutiny. According to a Wall Street Journal report, the drug maker has disclosed that it has been subpoenaed by the US Department of Justice over Avandia. According to Glaxo’s third-quarter … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia, Bisphosphonate Problems Point to Weaknesses in Drug Approval Process

Recent safety issues involving the diabetes drug < "">Avandia and a class of bone drugs called < "">bisphosphonates have some questioning the way drugs are approved for sale in the US. According to a recent New York Times’ news analysis, … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Alternatives Available

With the US Food and Drug Administration (FDA) severely restricting access to the diabetes medication, < "">Avandia, and the European Medicines Agency suggesting the controversial medication be banned, many diabetics are left wondering about safe alternatives. As we have written … Continue reading

Posted in Avandia, Pharmaceuticals |

GlaxoSmithKline Outlook Falls Following Avandia Restrictions

GlaxoSmithKline’s < "">Avandia problems are expected to take a toll on the drug maker’s bottom line. According to a Reuters report, analysts have already begun cutting Glaxo’s earnings forecast, after regulators in the US and Europe announced separate actions that … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Severely Restricted by FDA

Citing heart risks from < "">Avandia, the US Food & Drug Administration (FDA) has decided to place severe restrictions on the controversial diabetes drug. According to The New York Times, patients in the US will only have access to Avandia … Continue reading

Posted in Avandia, Pharmaceuticals |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.